Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals

Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...

CNS Pharmaceuticals Issues Letter to Shareholders

Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS Pharmaceuticals ...

CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Issues Letter to Shareholders

Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS PharmaceuticalsStrategic Focus, Pipeline Optimization and Formalizing Roadmap for Near and Long-Te ...
PharmiWeb

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

IGC Pharma adds New York site for Alzheimer’s disease trial

"IGC Pharma adds New York site for Alzheimer’s disease trial" was originally created and published by Clinical Trials Arena, ...
Nasdaq

CNS Pharma Stock Up Over 30%

(RTTNews) - Shares of CNS Pharmaceuticals, Inc. (CNSP) are up over 30% today, on no specific news. The company's pipeline is centered on TPI 287, a novel, blood-brain barrier permeable taxane ...
PharmiWeb

RWS Launches New CNS Rater Training Service to Strengthen Data Quality in Clinical Trials

Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trialMAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions ...

Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics

Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: APLT; "Applied"), a clinical-stage ...

Supernus: Outlook For 2026 Positive, Upholding Buy Rating

Qelbree-led growth, Sage acquisition synergies, and <4x forward P/S support ~25% upside into 2026. Click for more on SUPN ...

Cognision Launches Cognision360(TM): A Uni ed Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

Cognision today unveiled Cognision360(TM), a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, standardized system--addressing one of the ...

IGC Pharma, Inc.: IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial Site at Integrative Clinical Trials in New York

Multi-Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - POTOMAC, MD / ACCESS Newswire / January 22, 2026 / IGC Pharma, Inc. (NYSE America ...

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyUnique sublingual formulation ...